XKRX033780
Market cap7.80bUSD
Dec 20, Last price
107,600.00KRW
1D
-2.71%
1Q
0.47%
Jan 2017
6.53%
Name
KT&G Corp
Chart & Performance
Profile
KT&G Corporation, together with its subsidiaries, engages in the production and sale of tobacco and other products in South Korea. It provides tobacco and related materials, red ginseng, red ginseng products, other health foods, food and beverage products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment. In addition, it engages in the trading, real estate, leasing, and housing businesses. Further, the company engages in hotel development and management activities. KT&G Corporation was formerly known as Korea Tobacco and Ginseng Corporation and changed its name to KT&G Corporation in December 2002. The company was founded in 1987 and is headquartered in Daejeon, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 5,862,608,000 0.19% | 5,851,406,368 11.92% | 5,228,351,597 -1.38% | |||||||
Cost of revenue | 3,971,560,000 | 3,815,733,400 | 3,193,330,117 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,891,048,000 | 2,035,672,968 | 2,035,021,480 | |||||||
NOPBT Margin | 32.26% | 34.79% | 38.92% | |||||||
Operating Taxes | 318,836,000 | 415,601,989 | 415,440,944 | |||||||
Tax Rate | 16.86% | 20.42% | 20.41% | |||||||
NOPAT | 1,572,212,000 | 1,620,070,979 | 1,619,580,535 | |||||||
Net income | 902,662,000 -11.14% | 1,015,785,000 3.94% | 977,258,705 -16.60% | |||||||
Dividends | (776,434,000) | (575,903,630) | (595,583,630) | |||||||
Dividend yield | 7.76% | 5.26% | 6.09% | |||||||
Proceeds from repurchase of equity | (302,728,000) | (356,951,085) | (210,769,237) | |||||||
BB yield | 3.03% | 3.26% | 2.16% | |||||||
Debt | ||||||||||
Debt current | 107,799,000 | 93,314,291 | 94,779,612 | |||||||
Long-term debt | 544,067,000 | 137,466,457 | 109,130,003 | |||||||
Deferred revenue | 4,177,000 | 2,567,528 | 5,077,077 | |||||||
Other long-term liabilities | 117,366,000 | 132,095,941 | 138,708,655 | |||||||
Net debt | (3,318,529,000) | (3,451,651,242) | (2,778,335,844) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,265,993,000 | 887,886,607 | 1,419,821,289 | |||||||
CAPEX | (496,601,000) | (286,178,465) | (268,295,054) | |||||||
Cash from investing activities | (848,296,000) | 547,543,867 | (797,609,538) | |||||||
Cash from financing activities | (775,827,000) | (931,785,375) | (947,573,962) | |||||||
FCF | 1,008,598,987 | 1,357,571,366 | 1,949,726,396 | |||||||
Balance | ||||||||||
Cash | 1,668,989,000 | 1,995,199,513 | 2,369,012,083 | |||||||
Long term investments | 2,301,406,000 | 1,687,232,477 | 613,233,376 | |||||||
Excess cash | 3,677,264,600 | 3,389,861,671 | 2,720,827,879 | |||||||
Stockholders' equity | 10,015,849,000 | 16,941,459,659 | 16,045,613,386 | |||||||
Invested Capital | 6,344,601,400 | 5,225,891,583 | 5,667,139,724 | |||||||
ROIC | 27.18% | 29.75% | 28.01% | |||||||
ROCE | 18.53% | 23.14% | 23.84% | |||||||
EV | ||||||||||
Common stock shares outstanding | 115,096 | 119,657 | 123,731 | |||||||
Price | 86,900.00 -5.03% | 91,500.00 15.82% | 79,000.00 -4.93% | |||||||
Market cap | 10,001,857,173 -8.65% | 10,948,649,812 12.01% | 9,774,763,457 -6.44% | |||||||
EV | 6,821,679,173 | 7,539,934,204 | 7,046,503,565 | |||||||
EBITDA | 2,132,121,000 | 2,261,127,968 | 2,252,181,480 | |||||||
EV/EBITDA | 3.20 | 3.33 | 3.13 | |||||||
Interest | 45,878,000 | 34,772,000 | 17,844,000 | |||||||
Interest/NOPBT | 2.43% | 1.71% | 0.88% |